MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$2,373,800
EPS
-$4.46
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
Acquired in-process research and development
-
-
2,129,491.5*
Grant revenue
227,629
-
-
Research and development
1,304,345
749,813
92,042.5*
General and administrative
1,326,676
1,533,926
931,954*
Total operating expenses
2,631,021
2,283,739
3,153,488
Loss from operations
-2,631,021
-2,283,739
-3,153,488*
Interest income and other, net
29,592
59,111
23,868*
Loss from continuing operations
-
-2,224,628
-
Net loss
-2,373,800
-2,224,628
-3,129,620
Loss from continuing operation, total
-
-2,224,628
-
Loss from continuing operations attributable to common stockholders
-
-2,224,628
-3,129,620
Basic EPS
-4.46
-4.18
-32.275
Diluted EPS
-4.46
-4.18
-32.275
Basic Average Shares
531,968
531,968
96,967
Diluted Average Shares
531,968
531,968
96,967
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DCOY Income Statement Sankey DiagramSankey diagram visualizing DCOY income statement for the periodNet loss-$2,373,800 Grant revenue$227,629 Interest income andother, net$29,592 Loss from operations-$2,631,021 Total operatingexpenses$2,631,021 General andadministrative$1,326,676 Research and development$1,304,345

Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Inc. (DCOY)